Results 221 to 230 of about 50,598 (255)

Targeting ecto-5'-nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats. [PDF]

J Physiol
Nathanael D, Coney AM, Alotaibi D, Kumar P, Holmes AP.   +4 more
europepmc   +1 more source

A2AR as a key target for immune microenvironment remodeling in prostate cancer. [PDF]

Transl Oncol
Yan L, Yang Z, Zhao X, Chen Y, Wang Z.
europepmc   +1 more source

Special Issue "Purinergic Signalling in Physiology and Pathophysiology 2.0". [PDF]

Int J Mol Sci
Sluyter R.
europepmc   +1 more source

Expression of CD73 and VEGF in salivary gland carcinomas: associations with clinicopathological characteristics in Vietnamese population. [PDF]

BMC Cancer
Nguyen TD, Nguyen HT, Huynh CG, Thai TT, Bui TX, Thai TA, Duong TT, Nguyen MD, Vo DA, Pham UV, Nguyen DHT, Nguyen ANT.   +11 more
europepmc   +1 more source

Targeting CD39 as a Therapeutic for Cancer Immunotherapy. [PDF]

Expert Rev Mol Med
Li Z, Xu W, Kwok HF.
europepmc   +1 more source

Potential of Adora2b as an immunotherapeutic target for gastric cancer. [PDF]

Front Immunol
Li J, Shi R, Zhang X, Guo Z, Ji R.
europepmc   +1 more source

The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]

Purinergic Signal
da Silva FC, Stabile J, Fürstenau CR, Araújo TG.   +3 more
europepmc   +1 more source

Overcoming EGFR-Mediated Dendritic Cell Dysfunction to Enhance Anti-tumor Immunity in EGFR-Mutant NSCLC by Precisely Targeting CD73 With pH-responsive Nanocarriers. [PDF]

Adv Sci (Weinh)
Shang X, Geng X, Wang Z, Yuan S, Ding S, Liu N, Ma X, Sun X, Wang H, Sun Y, Qu X, Ren G, Li YQ, Wang X, Liu Y.   +14 more
europepmc   +1 more source

B and T Tumor-Infiltrating Lymphocyte Subtypes According to Subsite: A Colon Cancer Immunophenotyping Map. [PDF]

Biomedicines
Fagarasan G, Gheban BA, Fagarasan V, Crisan D, Telecan T, Bintintan VV, Seicean RI, Caziuc A, Dindelegan GC.   +8 more
europepmc   +1 more source

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target. [PDF]

Blood Adv
NaveenKumar SK, Newman TG, Mazetto Fonseca B, Yalavarthi S, Flores Nascimento MC, Sabb K, Kmetova K, Chong E, Sugur K, Ranger CH, Tompkins MP, Sarosh C, Madison JA, Tambralli A, Schaefer JK, Holinstat M, Zuo Y, Knight JS.   +17 more
europepmc   +1 more source